38128-93-7 Usage
Uses
Used in Pharmaceutical Industry:
(8Z,24E)-5,6,17,19-tetrahydroxy-8-[(2-hydroxyethoxy)amino]methylidene-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate is used as a potential pharmaceutical compound for its possible wide range of biological activities due to its complex structure and diverse functional groups.
Used in Drug Delivery Systems:
In the field of drug delivery, (8Z,24E)-5,6,17,19-tetrahydroxy-8-[(2-hydroxyethoxy)amino]methylidene-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate may be utilized as a component in the development of novel drug delivery systems, potentially enhancing the delivery, bioavailability, and therapeutic outcomes of associated pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 38128-93-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,1,2 and 8 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 38128-93:
(7*3)+(6*8)+(5*1)+(4*2)+(3*8)+(2*9)+(1*3)=127
127 % 10 = 7
So 38128-93-7 is a valid CAS Registry Number.
38128-93-7Relevant academic research and scientific papers
Oximes of 3 formylrifamycin SV. Synthesis, antibacterial activity, and other biological properties
Cricchio,Lancini,Tamborini,Sensi
, p. 396 - 403 (2007/10/06)
The synthesis of the oximes of 3 formylrifamycin SV and the preparation of some of the O substituted hydroxylamine intermediates are described. The chemical and physical characteristics, the antibacterial activity on wild type and rifampicin resistant strains, and other biological properties of the new derivatives are reported. Structure activity relationships show that increasing the lipophilicity of the oxime substituent decreases the antibacterial activity, both in vitro and in experimental infection, whereas inhibition of a rifampicin resistant strain of S. aureus and of several transcribing enzymes is increased.
